Overview
Atrial Fibrillation
Cancer Associated Thrombosis
The Promise of Factor XI
Abelacimab: A Novel Anticoagulant
Clinical Development Program
Our Mission
Our Team
Milestones & Achievements
Patient Advocacy
Healthcare Professionals
European Medical Journal
https://www.emjreviews.com/cardiology/article/the-azalea-timi-71-study-and-the-future-of-factor-xi-inhibition-reflections-from-the-american-heart-association-scientific-congress-2023-s020124/?utm_content=280095848&utm_medium=social&utm_source=linkedin&hss_channel=lcp-3321578